Consultee and commentator comments on the Appraisal Consultation Document Bristol Myers Squibb (also on behalf of Otsuka Pharmaceuticals): covering letter Bristol Myers Squibb (also on behalf of Otsuka Pharmaceuticals): response Royal College of Paediatrics and Child Health Comments on the Appraisal Consultation Document received through the NICE website This page was last updated: 29 November 2010